Effect of PP-01 on Cannabis Withdrawal Syndrome
Public ClinicalTrials.gov record NCT05494437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Multiple-Dose, Placebo Controlled Clinical Trial of Two Doses of PP-01 for the Mitigation of Cannabis Withdrawal Symptoms
Study identification
- NCT ID
- NCT05494437
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- PleoPharma, Inc.
- Industry
- Enrollment
- 234 participants
Conditions and interventions
Conditions
Interventions
- Gabapentin Drug
- Nabilone Drug
- PP-01 High Dose Combination Product
- PP-01 Low Dose Combination Product
- Placebo Drug
Drug · Combination Product
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 26, 2022
- Primary completion
- Aug 20, 2023
- Completion
- Aug 20, 2023
- Last update posted
- Aug 15, 2024
2022 – 2023
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Behavioral Research Specialists, LLC | Glendale | California | 91206 | — |
| Synergy San Diego | Lemon Grove | California | 91945 | — |
| Neuropsychiatric Research Institute | Orange | California | 92868 | — |
| CNS Clinical Research Group | Coral Springs | Florida | 33067 | — |
| Gulf Coast Clinical Research | Fort Myers | Florida | 33912 | — |
| Innovative Clinical Research Inc. | Lauderhill | Florida | 33319 | — |
| CenExel iResearch Atlanta, LLC | Decatur | Georgia | 30030 | — |
| CenExel iResearch Savannah, LLC | Savannah | Georgia | 31405 | — |
| Pillar Clinical Research, LLC | Chicago | Illinois | 60641 | — |
| Otrimed Research Center | Edgewood | Kentucky | 41017 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| Benchmark Research | Shreveport | Louisiana | 71101 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| North Star Medical Research | Middleburg Heights | Ohio | 44130 | — |
| Pahl Pharmaceutical Professionals LLC | Oklahoma City | Oklahoma | 73112 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29403 | — |
| Austin Clinical Trials | Austin | Texas | 78744 | — |
| Cedar Clinical Research | Draper | Utah | 84020 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05494437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2024 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05494437 live on ClinicalTrials.gov.